Cargando…
How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372624/ https://www.ncbi.nlm.nih.gov/pubmed/25848363 http://dx.doi.org/10.5114/pwki.2015.49177 |
| _version_ | 1782363213588856832 |
|---|---|
| author | Pracoń, Radosław Demkow, Marcin |
| author_facet | Pracoń, Radosław Demkow, Marcin |
| author_sort | Pracoń, Radosław |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4372624 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Termedia Publishing House |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43726242015-04-06 How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion Pracoń, Radosław Demkow, Marcin Postepy Kardiol Interwencyjnej Editorial Termedia Publishing House 2015-03-06 2015 /pmc/articles/PMC4372624/ /pubmed/25848363 http://dx.doi.org/10.5114/pwki.2015.49177 Text en Copyright © 2015 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Pracoń, Radosław Demkow, Marcin How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion |
| title | How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion |
| title_full | How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion |
| title_fullStr | How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion |
| title_full_unstemmed | How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion |
| title_short | How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion |
| title_sort | how to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372624/ https://www.ncbi.nlm.nih.gov/pubmed/25848363 http://dx.doi.org/10.5114/pwki.2015.49177 |
| work_keys_str_mv | AT praconradosław howtowalkthetightropebetweenharmandprotectioninselectingtheoptimalantiplatelettreatmentstrategyaftertranscatheterleftatrialappendageocclusion AT demkowmarcin howtowalkthetightropebetweenharmandprotectioninselectingtheoptimalantiplatelettreatmentstrategyaftertranscatheterleftatrialappendageocclusion |